The critical roles of HSDL2 in the pathogenesis of various diseases, such as cancer, Alzheimer’s disease, and obesity, involve the modulation of signaling and metabolic pathways [30–32]. Here, HSDL2 is linked to obesity due to melanocortin 4 receptor deficiency.